Reciprocity and post-trial access for participants in antiretroviral therapy trials

被引：19

作者：

Merritt, Maria ^{[1
]}

Grady, Christine

机构：

[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Phoebe R berman Bioeth Inst, Baltimore, MD USA

[3] NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA

来源：

AIDS | 2006年 / 20卷 / 14期

关键词：

bioethical issues; antiretroviral therapy; research subjects; clinical trials; developing countries;

D O I：

10.1097/01.aids.0000244197.88134.45

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1791 / 1794

页数：4

共 16 条

[1] Creation of a drug fund for post-clinical trial access to antiretrovirals [J].

Ananworanich, J ;

Cheunyam, T ;

Teeratakulpisam, S ;

Boyd, MA ;

Ruxrungtham, K ;

Lange, J ;

Cooper, D ;

Phanuphak, P .

LANCET, 2004, 364 (9428) :101-102

[2]

[Anonymous], DECL HELS

[3]

BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P173

[4]

Bennett S, 2005, B WORLD HEALTH ORGAN, V83, P541

[5]

Daniels N., 2004, ACHIEVE FAIR DISTRIB

[6]

Grady Christine, 2005, Yale J Health Policy Law Ethics, V5, P425

[7] Changing the presumption: Providing ART to vaccine research participants [J].

Macklin, R .

AMERICAN JOURNAL OF BIOETHICS, 2006, 6 (01) :W1-W5

[8]

Macklin R, 2004, ETHICS EQUITY ACCESS

[9] Which patients first? Setting priorities for antiretroviral therapy where resources are limited [J].

McGough, LJ ;

Reynolds, SJ ;

Quinn, TC ;

Zenilman, JM .

AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (07) :1173-1180

[10]

*NAT I HLTH, 2005, GUID ADDR PROV ANT T

← 1 2 →